Legato Capital Management LLC Axsome Therapeutics, Inc. Transaction History

Legato Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$69.39 - $97.64 $269,857 - $379,721	-3,889 Reduced 45.11%	4,733 $377,000
Q3 2023 Oct 12, 2023	BUY	$69.25 - $82.21 $597,073 - $708,814	8,622 New	8,622 $602,000
Q2 2023 Aug 17, 2023	BUY	$58.41 - $90.35 $287,669 - $444,973	4,925 Added 70.09%	11,952 $858,000
Q4 2022 Feb 01, 2023	BUY	$39.94 - $79.72 $280,658 - $560,192	7,027 New	7,027 $541,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Legato Capital Management LLC with notifications on news.